Current role
Biotechnology · Healthcare
Board Member
2020-07-23–present
Barry Flannelly, Pharm.D, MBA
Board Member
Protara Therapeutics, Inc. (TARA)Equibles does not estimate personal net worth.
Get an email with a short summary when Protara Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get TARA alertsAbout Barry Flannelly, Pharm.D, MBA
Barry Flannelly, Pharm.D, MBA is recorded as Board Member at Protara Therapeutics, Inc. (TARA) since July 23, 2020. Protara Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Protara Therapeutics, Inc. includes Jesse Shefferman (CEO and Board Member), Luke Beshar (Chairman), Blaine Davis (CFO) and 7 others.
Affiliation history
-
Current
2020-07-23–present
Company network
Leadership on record at Protara Therapeutics, Inc.
- Jesse Shefferman CEO, Board Member
- Luke Beshar Chairman
- Blaine Davis CFO
- Patrick Fabbio CFO
- Barry Flannelly Board Member
- Cynthia Smith Board Member
- Gregory Sargen Board Member
- Jane Huang Board Member
- Jane Huang, M.D. Board Member
- Michael Solomon Board Member
Recent activity
No call appearances or filed executive changes recorded yet.